UY32766A - Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen - Google Patents

Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Info

Publication number
UY32766A
UY32766A UY0001032766A UY32766A UY32766A UY 32766 A UY32766 A UY 32766A UY 0001032766 A UY0001032766 A UY 0001032766A UY 32766 A UY32766 A UY 32766A UY 32766 A UY32766 A UY 32766A
Authority
UY
Uruguay
Prior art keywords
new
pharmaceutical compositions
compositions containing
preparation procedure
compounds
Prior art date
Application number
UY0001032766A
Other languages
English (en)
Inventor
Lestage Pierre
Botez Iuliana
Lebreton Jacques
Louis Caroline
Mathe Monique
Original Assignee
Servier Lab
Univ Nantes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Univ Nantes filed Critical Servier Lab
Publication of UY32766A publication Critical patent/UY32766A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de fórmula (I): en la que: * R1 representa un átomo de hidrógeno o un grupo metilo, * R2 representa un átomo de bromo, un átomo de flúor o un grupo trifluorometilo. Medicamentos.
UY0001032766A 2009-07-21 2010-07-07 Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen UY32766A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903573A FR2948368B1 (fr) 2009-07-21 2009-07-21 Nouveaux composes piperidiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
UY32766A true UY32766A (es) 2011-01-31

Family

ID=41287719

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032766A UY32766A (es) 2009-07-21 2010-07-07 Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Country Status (29)

Country Link
US (1) US20110021569A1 (es)
EP (1) EP2277863A1 (es)
JP (1) JP2011037845A (es)
KR (1) KR20110009065A (es)
CN (1) CN101962355A (es)
AP (1) AP2010005328A0 (es)
AR (1) AR077418A1 (es)
AU (1) AU2010202875A1 (es)
BR (1) BRPI1004309A2 (es)
CA (1) CA2709551A1 (es)
CL (1) CL2010000742A1 (es)
CO (1) CO6240165A1 (es)
CR (1) CR11567A (es)
CU (1) CU20100151A7 (es)
EA (1) EA201001042A1 (es)
EC (1) ECSP10010358A (es)
FR (1) FR2948368B1 (es)
IL (1) IL206884A0 (es)
MA (1) MA32053B1 (es)
MX (1) MX2010007800A (es)
MY (1) MY150546A (es)
NZ (1) NZ586856A (es)
PE (1) PE20110155A1 (es)
SG (1) SG168483A1 (es)
SV (1) SV2010003626A (es)
TW (1) TW201116512A (es)
UY (1) UY32766A (es)
WO (1) WO2011010015A1 (es)
ZA (1) ZA201005204B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9861941B2 (en) 2011-07-12 2018-01-09 Kraton Polymers U.S. Llc Modified sulfonated block copolymers and the preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0495071A (ja) * 1990-08-10 1992-03-27 Kyorin Pharmaceut Co Ltd カルバミン酸誘導体
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
GB0510140D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B2

Also Published As

Publication number Publication date
MX2010007800A (es) 2011-04-20
CO6240165A1 (es) 2011-01-20
ZA201005204B (en) 2011-04-28
IL206884A0 (en) 2010-12-30
TW201116512A (en) 2011-05-16
NZ586856A (en) 2011-11-25
AU2010202875A1 (en) 2011-02-10
FR2948368A1 (fr) 2011-01-28
PE20110155A1 (es) 2011-03-19
JP2011037845A (ja) 2011-02-24
SV2010003626A (es) 2011-01-31
EA201001042A1 (ru) 2011-02-28
FR2948368B1 (fr) 2011-07-22
AR077418A1 (es) 2011-08-24
BRPI1004309A2 (pt) 2012-04-17
WO2011010015A1 (fr) 2011-01-27
AP2010005328A0 (en) 2010-08-31
CN101962355A (zh) 2011-02-02
CL2010000742A1 (es) 2011-07-08
MA32053B1 (fr) 2011-02-01
SG168483A1 (en) 2011-02-28
MY150546A (en) 2014-01-30
ECSP10010358A (es) 2011-02-28
CA2709551A1 (fr) 2011-01-21
CU20100151A7 (es) 2012-03-15
KR20110009065A (ko) 2011-01-27
EP2277863A1 (fr) 2011-01-26
CR11567A (es) 2010-10-08
US20110021569A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
UY30444A1 (es) Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
UY31260A1 (es) Compuestos de pirazol, composiciones conteniendolos y aplicaciones.
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
CO6741154A2 (es) Compuestos de triazolopiridina
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
CR20110269A (es) Lactamas como inhibidores de beta secretasa
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
ECSP13012838A (es) Nuevos compuestos de benzodioxol-piperazina
UY32766A (es) Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
NI201300028A (es) Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
HN2012000485A (es) Nuevos derivados dihidro-oxazolobenzonzodiazepinonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
ECSP088375A (es) Alquil sulfóxido quinolinas como ligandos del receptor nk-3
CR11494A (es) Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY33862A (es) Nuevos compuestos de benzamida, composiciones agroquímicas que los contienen, procesos de preparación y usos?
AR061741A1 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
TN2010000324A1 (en) New piperidine compounds a process for their preparation and pharmaceutical compositions containing them